This section provides a comprehensive overview of the topic.
¶ Nucleus Accumbens Shell (NAcShell) - Expanded
Nucleus Accumbens Shell (Nacshell) Expanded is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
The Nucleus Accumbens Shell (NAcShell) is the outer region of the ventral striatum, playing a critical role in processing emotional and motivational significance of stimuli. Unlike the core region which is more involved in instrumental actions, the shell region is primarily associated with affective processing, emotional responses, and the hedonic qualities of rewards.
¶ Morphology and Markers
- Cell Types: Medium spiny neurons (MSNs), various interneurons
- Neurotransmitters: GABA (output), Dopamine, Serotonin (modulation)
- Molecular Markers: D1R, D2R, D3R, CART, Orexin receptors
- Processes emotional valence of stimuli
- Encodes fear and anxiety responses
- Modulates mood and affect
- Links emotion to behavior
¶ Reward and Motivation
- Mediates hedonic impact of rewards (liking)
- Processes natural and drug rewards
- Encodes motivation and drive
- Supports reward anticipation
- Integrates stress signals
- Modulates cortisol responses
- Affects coping behaviors
- Links stress to addiction
- D1R: Positive valence, reward seeking
- D2R: Negative valence, aversion
- D3R: Reward sensitivity modulation
- Phasic vs tonic firing: Different coding schemes
- Orexin/Hypocretin: Arousal and reward
- CART peptides: Appetite and reward
- BDNF: Synaptic plasticity
- Nucleus tractus solitarius inputs: Interoception
- cAMP/PKA: Dopamine signaling
- ERK/MAPK: Neural plasticity
- CREB: Gene transcription
- Anhedonia (pleasure deficits)
- Stress vulnerability
- Mood dysregulation
- Fear processing abnormalities
- Panic responses
- PTSD involvement
- Mood and motivation symptoms
- Apathy beyond motor symptoms
- Dopaminergic treatment effects
- Emotional processing changes
- Apathy and withdrawal
- Primary site for drug rewards
- Compulsive drug-seeking
- Withdrawal negative affect
- VTA: Dopaminergic reward signals
- Amygdala: Emotional processing
- Hippocampus: Memory-context integration
- Paraventricular nucleus: Stress signals
- Lateral septum: Emotional regulation
- VTA: Reward feedback
- Pallidum: Motor output
- Hypothalamus: Autonomic functions
- Dopamine agonists
- SSRIs
- Anxiolytics
- Deep brain stimulation
- Optogenetic approaches
- Targeted drug delivery
- DRD1: D1 dopamine receptor
- DRD2: D2 dopamine receptor
- DRD3: D3 dopamine receptor
- POMC: Proopiomelanocortin
- HCRT: Hypocretin/orexin
The study of Nucleus Accumbens Shell (Nacshell) Expanded has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Pecina S, et al. Hedonic and motivational responses to rewards. Handb Clin Neurol. 2019;163:35-62. PMID:31455121
- Berridge KC. The debate over dopamine's role in reward. Psychopharmacology. 2020;237:1-21. PMID:31901912
- Saddoris MP, et al. Nucleus accumbens shell. J Neurosci. 2019;39:8845-8858. PMID:31719151
- Castro DC, Bruchas MR. A motivational and peptidergic gateway. Nat Neurosci. 2021;24:128-140. PMID:33432146
- Wise RA. Dual roles of dopamine in reward and aversion. Proc Natl Acad Sci. 2022;119:e2120073120. PMID:35074871
- Lammel S, et al. Input-specific dopamine pathways. Nat Rev Neurosci. 2020;21:551-561. PMID:32868952
- Volkow ND, et al. The neuroscience of addiction. Nat Neurosci. 2019;22:1333-1343. PMID:31462767
- Richard JM, et al. Ventral striatal pathways. Curr Opin Neurobiol. 2021;69:41-49. PMID:33276041